Therabron Therapeutics Appoints Eric Richman as an Independent Board Member

Therabron Therapeutics, Inc., a clinical-stage biotechnology company dedicated to advancing a new standard in respiratory care, today announced the appointment of Eric I. Richman as an independent director to the […]

By |April 4th, 2016|Recent News|

Therabron Therapeutics Expands Management Team

ROCKVILLE, MD, March 9, 2016 — Therabron Therapeutics, Inc., a clinical-stage biotechnology company dedicated to advancing a new standard in respiratory care, today announced senior management team appointments. Dr. […]

By |March 9th, 2016|Recent News|

Therabron Therapeutics Announces New Study Aimed at the Creation of Multiple Novel Isoforms of the Company’s Lead Product Candidate

ROCKVILLE, MD, March 2, 2016 — Therabron Therapeutics, Inc., a specialty biotechnology company dedicated to advancing a new standard in respiratory care, today announced presentation of data unveiling the creation […]

By |March 2nd, 2016|Recent News|

Therabron Therapeutics to Present at BioCentury 23rd Annual Future Leaders in the Biotech Industry Conference

ROCKVILLE, MD, February 23, 2016 — Therabron Therapeutics, Inc., a clinical-stage biotechnology company dedicated to advancing a new standard in respiratory care, today announced that its President and Chief Executive […]

By |February 23rd, 2016|Recent News|

Therabron Therapeutics to Present at the 2016 Biotech Showcase Conference

ROCKVILLE, MD, January 7, 2016 – Therabron Therapeutics, Inc., a specialty biotechnology company dedicated to redefining the management of respiratory disease through innovation, today announced that its President and Chief Executive Officer, […]

By |January 7th, 2016|Uncategorized|

Therabron Therapeutics Makes Strategic Changes and Expands Management Team

ROCKVILLE, MD, December 10, 2015 — Therabron Therapeutics, Inc., a clinical-stage biotechnology company dedicated to advancing a new standard in respiratory care, today announced new appointments and changes to the Company’s management […]

By |December 10th, 2015|Recent News|

Therabron Therapeutics Announces Favorable Infant Outcomes with Six-Month Follow-Up of a Phase 1b Recombinant Human CC10 Clinical Trial

ROCKVILLE, MD, December 8, 2015 — Therabron Therapeutics, Inc., a specialty biotechnology company dedicated to advancing a new standard in respiratory care, today presented a retrospective analysis of long-term follow-up data from […]

By |December 8th, 2015|Recent News|

Therabron Therapeutics Receives Accelerated Second Tranche from Series B Financing and Expands Investor Syndicate

ROCKVILLE, MD – November 9, 2015 – Therabron Therapeutics, Inc., a clinical-stage biotechnology company dedicated to advancing a new standard in respiratory care, today announced that the Company has received an accelerated […]

By |November 11th, 2015|Recent News|

Therabron Therapeutics to Participate in Upcoming Healthcare Conferences

ROCKVILLE, MD, October 15, 2015 – Therabron Therapeutics, Inc., a specialty biotechnology company dedicated to redefining the management of respiratory disease through innovation, today announced that it will participate in two […]

By |November 3rd, 2015|Recent News|

Therabron Therapeutics Reaches 50 Percent Enrollment in Phase 2 Clinical Trial for Lead Pediatric Respiratory Critical Care Program

ROCKVILLE, MD, July 21, 2015  — Therabron Therapeutics, Inc., a specialty biotechnology company dedicated to redefining the management of respiratory disease through innovation, today announced that it has achieved over […]

By |July 21st, 2015|Recent News|